医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
5期
873-875
,共3页
胆汁淤积%支架%穿刺术%内窥镜检查
膽汁淤積%支架%穿刺術%內窺鏡檢查
담즙어적%지가%천자술%내규경검사
Cholestasis%Stents%Punctures%Endoscopy
【目的】探讨应用不同方式胆道金属支架置入治疗肝外胆管恶性梗阻的效果,为临床上选择更适当的方法治疗晚期恶性梗阻性黄疸提供依据。【方法】回顾性分析本院2009年1月至2013年1月经内镜胆道金属支架置入术(EMBD)治疗肝外胆管恶性梗阻患者80例(EMBD组)及经皮肝穿刺胆管造影(PTC)胆道金属支架置入术治疗肝外胆管恶性梗阻患者80例(PTC组)的临床资料。比较两组的手术成功率、术后并发症发生率、支架通畅时间及患者生存期。【结果】两组患者术后肝功能均有明显改善,两组之间比较总胆红素(TB)、碱性磷酸酶(ALP)及谷氨酰基转移酶(GGT)下降程度无显著性差异(P>0.05),PTC组的手术成功率高于 EMBD组,但并发症的发生率明显高于 EMBD组(P<0.05)。两组病人术后支架通畅时间及生存期比较无显著性差异(P >0.05)。【结论】对于肝外胆道恶性梗阻患者可首选 EMBD,如手术失败可考虑经PTC途径行胆道支架置入。
【目的】探討應用不同方式膽道金屬支架置入治療肝外膽管噁性梗阻的效果,為臨床上選擇更適噹的方法治療晚期噁性梗阻性黃疸提供依據。【方法】迴顧性分析本院2009年1月至2013年1月經內鏡膽道金屬支架置入術(EMBD)治療肝外膽管噁性梗阻患者80例(EMBD組)及經皮肝穿刺膽管造影(PTC)膽道金屬支架置入術治療肝外膽管噁性梗阻患者80例(PTC組)的臨床資料。比較兩組的手術成功率、術後併髮癥髮生率、支架通暢時間及患者生存期。【結果】兩組患者術後肝功能均有明顯改善,兩組之間比較總膽紅素(TB)、堿性燐痠酶(ALP)及穀氨酰基轉移酶(GGT)下降程度無顯著性差異(P>0.05),PTC組的手術成功率高于 EMBD組,但併髮癥的髮生率明顯高于 EMBD組(P<0.05)。兩組病人術後支架通暢時間及生存期比較無顯著性差異(P >0.05)。【結論】對于肝外膽道噁性梗阻患者可首選 EMBD,如手術失敗可攷慮經PTC途徑行膽道支架置入。
【목적】탐토응용불동방식담도금속지가치입치료간외담관악성경조적효과,위림상상선택경괄당적방법치료만기악성경조성황달제공의거。【방법】회고성분석본원2009년1월지2013년1월경내경담도금속지가치입술(EMBD)치료간외담관악성경조환자80례(EMBD조)급경피간천자담관조영(PTC)담도금속지가치입술치료간외담관악성경조환자80례(PTC조)적림상자료。비교량조적수술성공솔、술후병발증발생솔、지가통창시간급환자생존기。【결과】량조환자술후간공능균유명현개선,량조지간비교총담홍소(TB)、감성린산매(ALP)급곡안선기전이매(GGT)하강정도무현저성차이(P>0.05),PTC조적수술성공솔고우 EMBD조,단병발증적발생솔명현고우 EMBD조(P<0.05)。량조병인술후지가통창시간급생존기비교무현저성차이(P >0.05)。【결론】대우간외담도악성경조환자가수선 EMBD,여수술실패가고필경PTC도경행담도지가치입。
[Objective]To explore the efficacy of different ways of metal stent placement for the treatment of advanced malignant obstructive jaundice in order to provide the basis for selecting better method for clinical treat-ment.[Methods]Clinical data of 80 patients with malignant extrahepatic biliary obstruction undergoing endoscopic biliary metal stent placement and 80 patients with malignant extrahepatic biliary obstruction undergoing percutane-ous transhepatic biliary metal stent placement in our hospital from Jan.2009 to Jan.2013 were analyzed retrospec-tively.The achievement ratio of operation,the incidence of postoperative complications,the unobstructed time of stents and the survival time of patients between two groups were compared.[Results]Liver function of two groups after operation was significantly improved.There was no significant difference in the decline of total bilirubin (TB),alkaline phosphatase(ALP)and gamma glutamyl transferase(GGT)between two groups.The achievement ratio of percutaneous transhepatic biliary metal stent placement was higher than that of endoscopic biliary metal stent placement,but the incidence of the complications of percutaneous transhepatic biliary metal stent placement was obviously higher than that of endoscopic biliary metal stent placement.There was no significant difference in the unobstructed time and survival time between two groups.[Conclusion]The first choice of treating the patients with malignant extrahepatic biliary obstruction is percutaneous transhepatic biliary metal stent placement.If the operation is failure,percutaneous transhepatic biliary stent placement by PTC can be considered.